CTX (CTX) News
Follow CTX (CTX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
Captor Therapeutics Signs $2 Million Grant Deal For NEK7 Project
Captor Therapeutics SA GPW:CTX
NEWS | Sep 29, 2026, 03:35 PM UTC
L
CTX: Net loss widened on lower R&D revenue, but equity strengthened after a major share issue
Revenue from R&D services declined sharply year-over-year, while net loss widened due to higher R&D costs. A major share issue in March 2026 strengthened equity and liquidity, and management expects sufficient resources
EARNINGS | Sep 15, 2026, 05:02 PM UTC
L
Captor Therapeutics H1 Net Loss At 22.8 Million Zlotys
Captor Therapeutics SA GPW:CTX
NEWS | Sep 15, 2026, 03:13 PM UTC